A high-level overview of Stoke Therapeutics, Inc. (STOK) stock. View (STOK) real-time stock price, chart, news, analysis, analyst reviews and more.

Zorevunersen is an investigational antisense oligonucleotide (ASO) that targets the SCN1A gene, which Biogen says is the underlying cause of most cases of Dravet syndrome, and is on the brink of ...

Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis ...